123 related articles for article (PubMed ID: 25576528)
21. The cost-effectiveness of male HPV vaccination in the United States.
Chesson HW; Ekwueme DU; Saraiya M; Dunne EF; Markowitz LE
Vaccine; 2011 Oct; 29(46):8443-50. PubMed ID: 21816193
[TBL] [Abstract][Full Text] [Related]
22. Immunization effects of a communication intervention to promote preteen HPV vaccination in primary care practices.
Cates JR; Crandell JL; Diehl SJ; Coyne-Beasley T
Vaccine; 2018 Jan; 36(1):122-127. PubMed ID: 29169892
[TBL] [Abstract][Full Text] [Related]
23. The predicted impact of HPV vaccination on male infections and male HPV-related cancers in Australia.
Smith MA; Lew JB; Walker RJ; Brotherton JM; Nickson C; Canfell K
Vaccine; 2011 Nov; 29(48):9112-22. PubMed ID: 21419773
[TBL] [Abstract][Full Text] [Related]
24. Impact of a clinical interventions bundle on uptake of HPV vaccine at an OB/GYN clinic.
Deshmukh U; Oliveira CR; Griggs S; Coleman E; Avni-Singer L; Pathy S; Shapiro ED; Sheth SS
Vaccine; 2018 Jun; 36(25):3599-3605. PubMed ID: 29759380
[TBL] [Abstract][Full Text] [Related]
25. Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia.
Gertig DM; Brotherton JM; Saville M
Sex Health; 2011 Jun; 8(2):171-8. PubMed ID: 21592430
[TBL] [Abstract][Full Text] [Related]
26. Identifying Area-Level Disparities in Human Papillomavirus Vaccination Coverage Using Geospatial Analysis.
Wheeler DC; Miller CA; Do EK; Ksinan AJ; Trogdon JG; Chukmaitov A; Fuemmeler BF
Cancer Epidemiol Biomarkers Prev; 2021 Sep; 30(9):1689-1696. PubMed ID: 34172461
[TBL] [Abstract][Full Text] [Related]
27. Acceptance and compliance with postpartum human papillomavirus vaccination.
Wright JD; Govindappagari S; Pawar N; Cleary K; Burke WM; Devine PC; Lu YS; Tsai WY; Lewin SN; Herzog TJ
Obstet Gynecol; 2012 Oct; 120(4):771-82. PubMed ID: 22996094
[TBL] [Abstract][Full Text] [Related]
28. Provider perceptions of barriers and facilitators of HPV vaccination in a high-risk community.
Javanbakht M; Stahlman S; Walker S; Gottlieb S; Markowitz L; Liddon N; Plant A; Guerry S
Vaccine; 2012 Jun; 30(30):4511-6. PubMed ID: 22561142
[TBL] [Abstract][Full Text] [Related]
29. The effects of a brief educational intervention on human papillomavirus knowledge and intention to initiate HPV vaccination in 18-26 year old young adults.
Kester LM; Shedd-Steele RB; Dotson-Roberts CA; Smith J; Zimet GD
Gynecol Oncol; 2014 Mar; 132 Suppl 1():S9-12. PubMed ID: 24384459
[TBL] [Abstract][Full Text] [Related]
30. Exploring variation in human papillomavirus vaccination uptake in Switzerland: a multilevel spatial analysis of a national vaccination coverage survey.
Riesen M; Konstantinoudis G; Lang P; Low N; Hatz C; Maeusezahl M; Spaar A; Bühlmann M; Spycher BD; Althaus CL
BMJ Open; 2018 May; 8(5):e021006. PubMed ID: 29773702
[TBL] [Abstract][Full Text] [Related]
31. The HPV vaccine: are dosing recommendations being followed?
Tan W; Viera AJ; Rowe-West B; Grimshaw A; Quinn B; Walter EB
Vaccine; 2011 Mar; 29(14):2548-54. PubMed ID: 21300098
[TBL] [Abstract][Full Text] [Related]
32. The impact of differential uptake of HPV vaccine by sexual risks on health inequalities: a model-based analysis.
Malagón T; Joumier V; Boily MC; Van de Velde N; Drolet M; Brisson M
Vaccine; 2013 Mar; 31(13):1740-7. PubMed ID: 23384753
[TBL] [Abstract][Full Text] [Related]
33. Sociodemographic factors predicting mother's cervical screening and daughter's HPV vaccination uptake.
Spencer AM; Roberts SA; Brabin L; Patnick J; Verma A
J Epidemiol Community Health; 2014 Jun; 68(6):571-7. PubMed ID: 24567443
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness of a provider-focused intervention to improve HPV vaccination rates in boys and girls.
Perkins RB; Zisblatt L; Legler A; Trucks E; Hanchate A; Gorin SS
Vaccine; 2015 Feb; 33(9):1223-9. PubMed ID: 25448095
[TBL] [Abstract][Full Text] [Related]
35. Uptake of the human papillomavirus-vaccination within the free-of-charge childhood vaccination programme in Denmark.
Widgren K; Simonsen J; Valentiner-Branth P; Mølbak K
Vaccine; 2011 Dec; 29(52):9663-7. PubMed ID: 22015392
[TBL] [Abstract][Full Text] [Related]
36. [Acceptability of vaccination against human papillomavirus (HPV) by pediatricians, mothers and young women in Ho Chi Minh City, Vietnam].
Phan DP; Pham QT; Strobel M; Tran DS; Tran TL; Buisson Y
Rev Epidemiol Sante Publique; 2012 Dec; 60(6):437-46. PubMed ID: 23137871
[TBL] [Abstract][Full Text] [Related]
37. Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: a transmission-dynamic modelling study.
Laprise JF; Drolet M; Boily MC; Jit M; Sauvageau C; Franco EL; Lemieux-Mellouki P; Malagón T; Brisson M
Vaccine; 2014 Oct; 32(44):5845-53. PubMed ID: 25131743
[TBL] [Abstract][Full Text] [Related]
38. Long-term impact of human papillomavirus vaccination on infection rates, cervical abnormalities, and cancer incidence.
Bogaards JA; Coupé VM; Xiridou M; Meijer CJ; Wallinga J; Berkhof J
Epidemiology; 2011 Jul; 22(4):505-15. PubMed ID: 21540743
[TBL] [Abstract][Full Text] [Related]
39. Trends in Human Papillomavirus Vaccination in Commercially Insured Children in the United States.
Chen ST; Huybrechts KF; Bateman BT; Hernández-Díaz S
Pediatrics; 2020 Oct; 146(4):. PubMed ID: 32928985
[TBL] [Abstract][Full Text] [Related]
40. HPV vaccination of adult women: an audit of Australian general practitioners.
Mazza D; Petrovic K; Chakraborty S
Aust N Z J Obstet Gynaecol; 2012 Dec; 52(6):528-33. PubMed ID: 23046059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
